Raily Aesthetic Medicine International Holdings Limited (HKG:2135)
0.1180
-0.0010 (-0.84%)
Sep 21, 2026, 3:58 PM HKT
HKG:2135 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 219.59 | 189.41 | 199.34 | 189.38 | 164.52 | 188.37 |
Revenue Growth | 15.93% | -4.98% | 5.26% | 15.11% | -12.66% | 14.48% |
Gross Profit Gross Profit Growth | 92.65 | 77.71 | 71.41 | 71.49 | 66.78 | 69.69 |
Operating Income Operating Income Growth | 18.66 | 5.18 | -18.87 | -22.52 | -20.39 | -19.57 |
Net Income Net Income Growth | 13.54 | 1.87 | -59.21 | -32.46 | -15.91 | -17.69 |
Earnings Per Share EPS Growth | 0.02 | 0.00 | -0.11 | -0.08 | -0.04 | -0.04 |
EPS Growth | 622.93% | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Aesthetic Medical Services Aesthetic Medical Services Growth | 156.25 | 152.91 | 142.1 | 174.91 | 151.66 | 183.71 |
Aesthetic medical device products Aesthetic medical device products Growth | 64.03 | 39.26 | 59.08 | 15.22 | 14.21 | 1.65 |
Consulting Services Consulting Services Growth | 3.47 | 3.67 | 0.03 | - | 0.03 | 3.17 |
Elimination of Intersegment Sales Elimination of Intersegment Sales Growth | -4.16 | -6.43 | -1.87 | -0.75 | -1.38 | -0.17 |
Total Total Growth | 219.59 | 189.41 | 199.34 | 189.38 | 164.52 | 188.37 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 48.67 | 57.79 | 28.87 | 39.79 | 78.78 | 124.89 |
Total Debt Total Debt Growth | 49.85 | 59.15 | 56.37 | 51.78 | 48.22 | 67.45 |
Net Cash (Debt) Net Cash Growth | -1.17 | -1.36 | -27.5 | -11.99 | 30.56 | 57.44 |
Net Cash Growth | - | - | - | - | -46.80% | -56.88% |
Net Cash Per Share Net Cash Per Share Growth | -0.00 | -0.00 | -0.05 | -0.03 | 0.07 | 0.14 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 29.42 | 36.71 | 6.01 | 8.02 | -2.28 | -2.47 |
Capital Expenditures CapEx Growth | -25.84 | -2.73 | -8.64 | -18 | -18.85 | -15.77 |
Free Cash Flow Free Cash Flow Growth | 3.58 | 33.98 | -2.64 | -9.98 | -21.13 | -18.23 |
Free Cash Flow Growth | -89.47% | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 42.19% | 41.03% | 35.82% | 37.75% | 40.59% | 37.00% |
Operating Margin | 8.50% | 2.73% | -9.47% | -11.89% | -12.39% | -10.39% |
Pretax Margin | 6.18% | 0.01% | -32.74% | -18.49% | -13.43% | -12.18% |
Profit Margin | 6.17% | 0.99% | -29.70% | -17.14% | -9.67% | -9.39% |
FCF Margin | 1.63% | 17.94% | -1.32% | -5.27% | -12.84% | -9.68% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 4.24 | 40.09 | - | - | - | - |
P/FCF Ratio | 16.05 | 2.21 | - | - | - | - |
PS Ratio | 0.26 | 0.40 | 0.28 | 0.96 | 1.76 | 2.67 |